Skip to content
healthcare.dev

Rizatriptan Benzoate

NDC 65862-625, Rizatriptan Benzoate, tablet, orally disintegrating, from Aurobindo Pharma Limited.

Product NDC
65862-625
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203062
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-625 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIZATRIPTAN BENZOATE5 mg/1

Pharmacologic classes

Serotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Package NDCNDC-11Package
65862-625-12658620625124 BLISTER PACK in 1 CARTON (65862-625-12) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-03)
65862-625-18658620625183 BLISTER PACK in 1 CARTON (65862-625-18) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-06)
65862-625-36658620625369 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-625-36)
65862-625-486586206254818 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-625-48)
65862-625-64658620625641 BLISTER PACK in 1 CARTON (65862-625-64) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-03)
65862-625-90658620625903 BLISTER PACK in 1 CARTON (65862-625-90) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a8e37688-426c-4290-933d-54a34ae86000
  • NADAC price for package 65862062512

    GET /v1/drugs/nadac/65862062512
  • NADAC price for package 65862062590

    GET /v1/drugs/nadac/65862062590

Use it

Look up 65862-625 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-625 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-625. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.